83 related articles for article (PubMed ID: 3152531)
21. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
22. IgE-Fc epsilonRI-mast cell axis in the allergic cycle.
Pawankar R; Ra C
Clin Exp Allergy; 1998 Aug; 28 Suppl 3():6-14. PubMed ID: 9756181
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells.
Riccardi VM
Birth Defects Orig Artic Ser; 1981; 17(2):129-45. PubMed ID: 6802200
[TBL] [Abstract][Full Text] [Related]
24. Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1.
Tucker T; Riccardi VM; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Histochem Cytochem; 2011 Jun; 59(6):584-90. PubMed ID: 21525187
[TBL] [Abstract][Full Text] [Related]
25. Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance.
Salamon P; Shoham NG; Puxeddu I; Paitan Y; Levi-Schaffer F; Mekori YA
J Allergy Clin Immunol; 2008 Feb; 121(2):448-455.e5. PubMed ID: 18028996
[TBL] [Abstract][Full Text] [Related]
26. Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts.
Wang SW; Oh CK; Cho SH; Hu G; Martin R; Demissie-Sanders S; Li K; Moyle M; Yao Z
J Allergy Clin Immunol; 2005 Feb; 115(2):287-94. PubMed ID: 15696083
[TBL] [Abstract][Full Text] [Related]
27. Mast cell Fc epsilonRI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensis infection and can be up-regulated by in vivo administration of IgE.
Shaikh N; Rivera J; Hewlett BR; Stead RH; Zhu FG; Marshall JS
J Immunol; 1997 Apr; 158(8):3805-12. PubMed ID: 9103447
[TBL] [Abstract][Full Text] [Related]
28. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues.
Hirota S; Nomura S; Asada H; Ito A; Morii E; Kitamura Y
Arch Pathol Lab Med; 1993 Oct; 117(10):996-9. PubMed ID: 7692836
[TBL] [Abstract][Full Text] [Related]
30. Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication.
Moyer KE; Saggers GC; Ehrlich HP
Wound Repair Regen; 2004; 12(3):269-75. PubMed ID: 15225205
[TBL] [Abstract][Full Text] [Related]
31. In vitro responses of neurofibroma fibroblasts, mast cells and Schwann cells obtained from patients with neurofibromatosis 1 to 308-nm excimer light and/or vitamin D3.
Nakayama J; Sato C; Imafuku S
J Dermatol; 2013 Sep; 40(9):743-5. PubMed ID: 23855960
[TBL] [Abstract][Full Text] [Related]
32. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of fibroblasts and mast cells in chronic submandibular sialadenitis.
Epivatianos A; Zaraboukas T; Poulopoulos A; Harrison JD
Oral Dis; 2008 Apr; 14(3):259-63. PubMed ID: 18336373
[TBL] [Abstract][Full Text] [Related]
34. Distribution of the degranulated and non-degranulated mast cells in nasal polyp.
Sasaki Y
Acta Otolaryngol Suppl; 1986; 430():34-8. PubMed ID: 3461683
[TBL] [Abstract][Full Text] [Related]
35. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Parisier SC
Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
[TBL] [Abstract][Full Text] [Related]
36. Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".
Claman HN; Choi KL; Sujansky W; Vatter AE
J Immunol; 1986 Sep; 137(6):2009-13. PubMed ID: 3745920
[TBL] [Abstract][Full Text] [Related]
37. Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio.
Plante S; Semlali A; Joubert P; Bissonnette E; Laviolette M; Hamid Q; Chakir J
J Allergy Clin Immunol; 2006 Jun; 117(6):1321-7. PubMed ID: 16750993
[TBL] [Abstract][Full Text] [Related]
38. [Mastocytes in chronic inflammation of middle ear mucosa].
Sanković S; Dergenc R; Bojić P
Srp Arh Celok Lek; 1999; 127(1-2):35-8. PubMed ID: 10377839
[TBL] [Abstract][Full Text] [Related]
39. Mast cell, a promising therapeutic target in tubulointerstitial fibrosis.
Li Y; Liu FY; Peng YM; Li J; Chen J
Med Hypotheses; 2007; 69(1):99-103. PubMed ID: 17257770
[TBL] [Abstract][Full Text] [Related]
40. Electron microscopical study on the tumor of von Recklinghausen's neurofibromatosis.
Kimura M; Kamata Y; Matsumoto K; Takaya H
Acta Pathol Jpn; 1974 Jan; 24(1):79-91. PubMed ID: 4207546
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
